Clinical Trial Update: Molecular Imaging Probes to Inform Heterogeneity in Idiopathic Pulmonary Fibrosis [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating molecular imaging probes to inform heterogeneity in idiopathic pulmonary fibrosis. Sponsored by the University of Alabama…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Idiopathic Pulmonary Fibrosis | Phase 1 | Status: RECRUITING